APPLIED THERAPEUTICS INC (APLT)
US03828A1016 - Common Stock
ChartMill assigns a Buy % Consensus number of 88% to APLT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.06. This target is 52.35% above the current price.
APLT was analyzed by 12 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about APLT.
In the previous month the buy percentage consensus was at a similar level.
APLT was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-19 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-09-19 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-27 | Citigroup | Maintains | Buy -> Buy |
| 2024-07-31 | William Blair | Initiate | Outperform |
| 2024-07-17 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-04-11 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-26 | RBC Capital | Initiate | Outperform |
| 2024-03-15 | UBS | Maintains | Buy -> Buy |
| 2024-03-06 | UBS | Maintains | Buy -> Buy |
| 2024-02-22 | Leerink Partners | Initiate | Outperform |
| 2024-02-16 | Citigroup | Maintains | Buy -> Buy |
| 2023-04-25 | Baird | Maintains | Outperform |
| 2023-04-05 | Citigroup | Maintains | Buy |
| 2022-08-17 | Citigroup | Maintains | Buy |
| 2022-08-16 | Barclays | Maintains | Equal-Weight |
| 2022-05-20 | Citigroup | Maintains | Buy |
| 2022-01-04 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2021-08-27 | Goldman Sachs | Downgrade | Neutral -> Sell |